Serum monokine induced by gamma interferon as a novel biomarker for coronary artery calcification in humans

Coronary Artery Disease

Volumn 26, Issue 4, 2015, Pages 317-321

  Yu, Hee Tae ^a,b   Oh, Jaewon ^b   Chang, Hyuk Jae ^b   Lee, Sang Hak ^b   Shin, Eui Cheol ^a   Park, Sungha ^b  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Yonsei University Health System   (South Korea)

Author keywords

chemokine; coronary artery calcium score; monokine induced by gamma interferon

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CXCL9 CHEMOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL; BIOLOGICAL MARKER; CXCL9 PROTEIN, HUMAN;

AGATSTON SCORE; AGE; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; MIDDLE AGED; VASCULAR CALCIFICATION;

AGED; BIOMARKERS; CHEMOKINE CXCL9; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; VASCULAR CALCIFICATION;

EID: 84946903033     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000236     Document Type: Article

References (17)

1. Epstein FH, Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000; 102:2919-2922.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
4. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26:2421-2432.
5. Zernecke A, Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol 2014; 34:742-750.
6. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999; 104:1041-1050.
7. Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145:33-43.
8. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013; 38:1092-1104.
9. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. Increased Th1 activity in patients with coronary artery disease. Cytokine 2004; 26:131-137.
10. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358:1336-1345.
11. Hamirani YS, Pandey S, Rivera JJ, Ndumele C, Budoff MJ, Blumenthal RS, Nasir K. Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis 2008; 201:1-7.
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-832.
13. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56:1397-1406.
14. Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, et al. Immunosenescent CD8 + T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 2013; 62:126-133.
15. Gallo A, Saad A, Ali R, Dardik A, Tellides G, Geirsson A. Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice. J Thorac Cardiovasc Surg 2012; 143:704-710.
16. Lichtman AH, Binder CJ, Tsimikas S, Witztum JL. Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 2013; 123:27-36.
17. Van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA, et al. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:251-257.